Cape Verde interested in Cuba’s biotech products

Havana, Jul 16 (Prensa Latina) A delegation from Cape Verde that visited Cuba's Center for Genetic Engineering and Biotechnology (CIGB) showed interest in the products produced at the center, it was announced on Saturday.

According to the information posted on social networks by the scientific institution, the visiting delegation, made up of Minister of Education Amadeu Cruz, Deputy Minister of Public Health Evandro Monteiro, and Ambassador to Cuba Edna Barreto, were briefed about the CIGB’s main projects.

According to the source, the Cape Verdean officials were informed on the peculiarities of the Mambisa vaccine candidate and the Abdala vaccine, with which most of the adult population in Cuba is protected against the SARS-CoV-2.

Monteiro was also interested in the leading product Heberprot-P, a drug to treat patients suffering from diabetic foot ulcers in advanced stages and at high risk of amputation.

He explained that in his country there is a high incidence of diabetes, and commented on the benefits of having a drug with such effects.